In vitro antimicrobial activities and therapeutic effect of cefpiramide (SM-1652) on respiratory tract infections

Ktkuo Onuma; Seiichi Aonuma; Akira Watanabe; Masako Sasaki; Kotaro Oizumi; Kiyoshi Konno

doi:10.11250/chemotherapy1953.31.Supplement1_229

In vitro antimicrobial activities and therapeutic effect of cefpiramide (SM-1652) on respiratory tract infections

Ktkuo Onuma, Seiichi Aonuma, Akira Watanabe, Masako Sasaki, Kotaro Oizumi, Kiyoshi Konno

Research output: Contribution to journal › Article › peer-review

Abstract

From the results of in vitro tests, cefpiramide (CPM, SM-1652) was shown to be active against patient's strains of at least 2 species, S. aureus and P. aeruginosa. Twelve patients of respiratory tract infections were treated with 2 g a day of cefpiramide. Clinical responses were excellent in 6 cases, good in 4 and poor in 2. As for side effects, exanthema, discomfort of the chest and discomfort of the lower extremities were observed in 1 case each. Elevation of transaminases was seen in 4 cases.

Original language	English
Pages (from-to)	229-232
Number of pages	4
Journal	Chemotherapy
Volume	31
DOIs	https://doi.org/10.11250/chemotherapy1953.31.Supplement1_229
Publication status	Published - 1983 Jan 1

ASJC Scopus subject areas

Pharmacology (medical)
Infectious Diseases
Pharmacology
Drug Discovery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.11250/chemotherapy1953.31.Supplement1_229

Cite this

@article{82d0aca5bbb846cca2fbe771a66999b5,

title = "In vitro antimicrobial activities and therapeutic effect of cefpiramide (SM-1652) on respiratory tract infections",

abstract = "From the results of in vitro tests, cefpiramide (CPM, SM-1652) was shown to be active against patient's strains of at least 2 species, S. aureus and P. aeruginosa. Twelve patients of respiratory tract infections were treated with 2 g a day of cefpiramide. Clinical responses were excellent in 6 cases, good in 4 and poor in 2. As for side effects, exanthema, discomfort of the chest and discomfort of the lower extremities were observed in 1 case each. Elevation of transaminases was seen in 4 cases.",

author = "Ktkuo Onuma and Seiichi Aonuma and Akira Watanabe and Masako Sasaki and Kotaro Oizumi and Kiyoshi Konno",

year = "1983",

month = jan,

day = "1",

doi = "10.11250/chemotherapy1953.31.Supplement1_229",

language = "English",

volume = "31",

pages = "229--232",

journal = "CHEMOTHERAPY",

issn = "0009-3165",

}

TY - JOUR

T1 - In vitro antimicrobial activities and therapeutic effect of cefpiramide (SM-1652) on respiratory tract infections

AU - Onuma, Ktkuo

AU - Aonuma, Seiichi

AU - Watanabe, Akira

AU - Sasaki, Masako

AU - Oizumi, Kotaro

AU - Konno, Kiyoshi

PY - 1983/1/1

Y1 - 1983/1/1

N2 - From the results of in vitro tests, cefpiramide (CPM, SM-1652) was shown to be active against patient's strains of at least 2 species, S. aureus and P. aeruginosa. Twelve patients of respiratory tract infections were treated with 2 g a day of cefpiramide. Clinical responses were excellent in 6 cases, good in 4 and poor in 2. As for side effects, exanthema, discomfort of the chest and discomfort of the lower extremities were observed in 1 case each. Elevation of transaminases was seen in 4 cases.

AB - From the results of in vitro tests, cefpiramide (CPM, SM-1652) was shown to be active against patient's strains of at least 2 species, S. aureus and P. aeruginosa. Twelve patients of respiratory tract infections were treated with 2 g a day of cefpiramide. Clinical responses were excellent in 6 cases, good in 4 and poor in 2. As for side effects, exanthema, discomfort of the chest and discomfort of the lower extremities were observed in 1 case each. Elevation of transaminases was seen in 4 cases.

UR - http://www.scopus.com/inward/record.url?scp=0020578502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020578502&partnerID=8YFLogxK

U2 - 10.11250/chemotherapy1953.31.Supplement1_229

DO - 10.11250/chemotherapy1953.31.Supplement1_229

M3 - Article

AN - SCOPUS:0020578502

SN - 0009-3165

VL - 31

SP - 229

EP - 232

JO - CHEMOTHERAPY

JF - CHEMOTHERAPY

ER -

In vitro antimicrobial activities and therapeutic effect of cefpiramide (SM-1652) on respiratory tract infections

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this